Shows
Living Legends & Luminaries In Endovascular MedicineRevolutionizing Cardiac Surgery | Dr. Kendra Grubb's Story🎙️Living Legends and Luminaries in Endovascular Medicine | Episode 3: Dr. Kendra GrubbIn this episode, Drs. Zvonimir Krajcer and Stephanie Coulter sit down with Dr. Kendra Grubb as she shares her inspiring journey from aspiring surgeon to a leader in endovascular therapies. Discover how her unique childhood experiences shaped her career path, her pioneering role as one of the few women in cardiothoracic surgery, and her dedication to advancing transcatheter technologies. Notably, Dr. Grubb candidly shares her belief that "...the way that we train surgeons is probably a little dated, and it leaves a lot of room f...2025-05-2839 min
JSCAI BEATSSCAI Expert Consensus Statement on Alternative Access for TAVRSandeep Nathan, MD, MSc, FACC, FSCAI, Matthew Sherwood, MD, FSCAI, Kendra Grubb, MD, Adam Greenbaum, MD, FSCAI discuss the SCAI Expert Consensus Statement published in JSCAI. The panel provides an insightful overview of the expert consensus, highlighting that alternative access is essential for a small subset of TAVR patients. It emphasizes the most effective techniques, the importance of a collaborative, multidisciplinary approach in patient selection, and the need to recognize institutional resources and operator capabilities for optimal patient outcomes. Additionally, the panel explores how cutting-edge advancements in device technology and imaging are revolutionizing the safety and precision of alternative...2025-05-1618 min
Luminaries in Structural Heart.Pioneering Structural Heart Interventions, the journey of Dr. Ashok Seth on TAVR, Innovation & the Future of CardiologyThis podcast episode features our host, Dr. Kendra Grubb, conversing with our guest, Dr. Ashok Seth, a renowned interventional cardiologist. Dr. Seth discusses his pioneering work introducing TAVR and other interventional technology to India and Asia over the past 30 years.
Dr. Seth performed the first TAVR CoreValve self-expandable in India in 2004, marking a significant milestone in interventional cardiology. Social attitudes and a lack of reimbursement are additional barriers to TAVI adoption among the elderly in India; India has a unique patient population with more bicuspid cases and smaller annuli, which influences valve choice during procedures. Dr. Seth emphasizes...2025-02-1133 min
The Cardiac ExchangeDiversity in Healthcare (Segment 3)Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way.2021-09-2127 minThe Cardiac ExchangeDiversity in Healthcare (Segment 2)Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way.2021-09-2112 minThe Cardiac ExchangeDiversity in Healthcare (Segment 1)Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way.2021-09-2114 minThe Cardiac ExchangeCOVID and Cardiac Surgery – Where are we now? (Segment 3)The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are moving forward.2021-08-1616 minThe Cardiac ExchangeCOVID and Cardiac Surgery – Where are we now? (Segment 2)The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are moving forward.2021-08-1616 min
The Cardiac ExchangeCOVID and Cardiac Surgery – Where are we now? (Segment 1)The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are moving forward.2021-08-1219 min
Health Professional Radio - PodcastSCAI 2021 - Study Shows Promising Outcomes for Evolut™ TAVR SystemReturning guest, Dr. Kendra Grubb, surgical director of the Structural Heart and Valve Center at Emory Healthcare in Atlanta discusses Medtronic's announcement of early results from the OPTIMIZE PRO clinical study at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions. The study evaluated procedure-related techniques and care pathways when using the self-expanding, supra-annular Evolut™ PRO and PRO+ TAVR systems in patients with symptomatic severe aortic stenosis.
Dr. Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. Prior to joining Emory, Dr. Grubb was the director of minimally invasive cardiac su...2021-05-2709 min
Health Professional Radio - PodcastActive Living Awareness Initiative - A Clinician PerspectiveDr. Kendra Grubb, surgical director of the Emory Structural Heart and Valve Center in Atlanta discusses data from a national survey released by patient advocacy group Heart-Valve-Surgery.com and supported by Medtronic, of more than 3400 heart valve patients and caregivers about managing heart valve disease and how a return to "active living" is key in their treatment decision. The findings from the survey were the impetus for the "Active Living" Initiative.2020-09-1100 min
Parallax by Ankur Kalra19: Women in Cardiology with Kendra GrubbThe first female cardiac surgeon qualified in the 1960’s. Today there are only 4.5% women in cardiology and only 4% in thoracic surgery. Ankur Kalra meets with Dr Kendra Grubb, the first women to be trained at the University of Virginia, US, on cardiothoracic surgery and the 250th board certified women in thoracic surgery.
Her recent post on social media went viral. It was a photo of an all-women surgical team carrying out a complex structural heart procedure. It had over 100,000 views and was seen by people in over 75 different countries. It’s clear from this online reaction, that now is the time...2020-02-1041 min
MDedge CardiocastCard Talk: TAVR and glass ceilingsThis week’s Cardiocast is devoted entirely to Card Talk with cardiologist brothers Jim and Jerry Dwyer. They welcome two structural interventionalists at the Structural Heart and Valve Center at Emory Healthcare, Kendra J. Grubb, MD, and Isida Byku, MD. Both followed a unique track, training in both cardiac surgery and interventional cardiology and practicing in the fast-moving field of structural heart disease. *  *  *  Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 *  *  *  From the “picture that went around the world” of an all-female t...2019-11-2943 min
Voices of Women as OneEpisode 15 - The Picture Seen Around the WorldInterview with: Kendra J. Grubb, MD, MHA
Surgical Director, Structural Heart and Valve
Emory University School of Medicine2019-10-1700 min
Advancing Your Health with Emory HealthcareThe Latest Heart Valve Disease Treatment OptionsMore than five million Americans have moderate or severe heart valve disease. Left undiagnosed and untreated, their condition can causeprogressive deterioration in heart function, which can result in heart failure and premature death. Kendra Grubb, MD, MHA, FACC, discusses the latest heart valve disease treatment options available at Emory HealthCare.2018-10-1500 minAdvancing Your Health with Emory HealthcareTAVR: Minimally Invasive Treatment for Aortic StenosisTranscatheter Aortic Valve Replacement (TAVR) is a minimally invasive treatment option for patients with severe aortic stenosis (narrowing of the aortic valve). The Emory TAVR program began in 2007 within the PARTNER I clinical trial and to-date over 2,500 patients have received this groundbreaking therapy at Emory HealthCare. Kendra Grubb, MD, discusses TAVR, and why you might consider this treatment option.2018-10-1500 min